Recent Press Releases

Amgen to terminate participation in co-development and commercialization of brodalumab

Amgen to terminate participation in co-development and commercialization of brodalumab THOUSAND OAKS, Calif., May 22, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Company has...

GSK submits Japan regulatory application for mepolizumab in severe eosinophilic asthma

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the submission of a regulatory application to the Japanese Ministry of Health, Labour and Welfare (MHLW) for mepolizumab as an add-on maintenance...

Omidria® Receives Positive Opinion from European Medicines Agency's Committee for Medicinal Products for Human Use

SEATTLE, May 22, 2015 -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both...

Cellular Biomedicine Group Announces Positive Phase I Results From CAR-T CD30 Immuno-Oncology Clinical Development Program

SHANGHAI, China and PALO ALTO, Calif., May 22, 2015 -- Cellular Biomedicine Group Inc. (CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective...

Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx

SHANGHAI -- A consortium ("the Consortium") consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, China Everbright Limited's healthcare fund...

Novartis announces two positive US phase III programs in COPD for QVA149 and NVA237

QVA149 improved lung function, breathlessness and health-related quality of life in moderate-to-severe COPD patients, according to EXPEDITION trial results[1]-[7] GEM 1 & 2 studies showed...

Nabriva Appoints Elyse Seltzer MD As Chief Medical Officer

Dr William Prince appointed to role of Senior Vice President, Clinical Science Vienna / Philadelphia, 21 May 2015: Nabriva Therapeutics AG, a clinical stage biopharmaceutical company engaged in the...

Mitogenetics Hires Innovative Team Of Scientists To Help Lead Breakthrough In Mitochondrial Dysfunction Research

Mitogenetics, a biomedical technology firm headquartered in South Dakota, today announced the hiring of four scientists to help accelerate the innovation that will lead to major breakthroughs in...

James S. Shannon Rejoins MannKind Corporation (MNKD)'s Board of Directors

VALENCIA, Calif., May 21, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that James S. Shannon, MD, MRCP (UK) has been elected to the company's Board of Directors...

Advaxis, Inc. Appoints Fred J. Frullo Vice President, Regulatory Affairs

PRINCETON, N.J., May 21, 2015 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced that it has appointed Fred J....

Bruker Corporation Announces Resignation Of Chief Financial Officer And Appointment Of Interim Chief Financial Officer

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) today announced that on May 19, 2015, Mr. Charles F. Wagner, Jr., Executive Vice President and the Chief Financial Officer (CFO)...

Synereca Pharmaceuticals Appoints Dr. Mark Corrigan To Its Board Of Directors

OKLAHOMA CITY, May 20, 2015 /PRNewswire/ -- Synereca Pharmaceuticals, Inc. (SPI), a research-stage biopharmaceutical company developing compounds that restore or increase the effectiveness of...

OvaScience Announces Ravi Mehrotra, Ph.D., Joins as Chief Corporate Development Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that...

MPM Capital Appoints Pablo J. Cagnoni, M.D., Former Onyx (AMGN) President, As Managing Director And CEO Of MPM Immunotherapy Portfolio Company Vesuvius.

SAN FRANCISCO--(BUSINESS WIRE)--MPM Capital announces the appointment of former President of Onyx Pharmaceuticals Pablo J. Cagnoni, M.D. as Managing Director (MD). In addition to serving as an MPM...

amp biosimilars AG Strengthens Management And Supervisory Boards

- Gunnar Janssen switching from the Supervisory as CFO to the Management Board - Dr Thomas Zimmer (formerly with Boehringer Ingelheim) appointed new Chairman of the Supervisory Board - Strengthening...

Allergen Research Corporation Names Mark McDade as Chairman and Mark Iwicki as Member of the Board of Directors

BRISBANE, Calif.--(BUSINESS WIRE)--Allergen Research Corporation (ARC), a privately held biopharmaceutical company developing desensitization treatments for food allergies, today announced additions...

Courtagen Life Sciences, Inc. Appoints Thomas Fairfield To The Company's Board Of Directors.

WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, Inc., a commercial-stage, innovative molecular information company that sells proprietary genomic diagnostic and drug metabolism assays for...

Former Chairman Of The Joint Chiefs Of Staff U.S. General Peter Pace Joins Pathway Genomics Corporation Board Of Directors

SAN DIEGO--(BUSINESS WIRE)--Pathway Genomics Corporation, a data-driven global healthcare company and precision medicine clinical laboratory announced today that the sixteenth Chairman of the Joint...

Adaptimmune Announces New Additions To Senior Clinical Management

OXFORD, UK and PHILADELPHIA, May 20, 2015 (GLOBE NEWSWIRE) -- Adaptimmune (Nasdaq:ADAP), a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today...

Clarus Ventures Promotes Michele Park, Ph.D., To Partner

CAMBRIDGE, Mass. and SOUTH SAN FRANCISCO, Calif., May 18, 2015 /PRNewswire/ -- Clarus Ventures, a leading life science investment firm, announced today the promotion of Michele Park, Ph.D., to...